(Q80161766)
Statements
[Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis] (English)
C Botsios
P Sfriso
A Furlan
P Ostuni
M Biscaro
U Fiocco
S Todesco